Skip to main content
Newsorga

Health

Health pages collect clinical evidence, public-health policy, access and pricing fights, and outbreak science when wellbeing systems or populations—not a lone product review—are the focus.

21 Newsorga stories grouped around “Health”, published from 2026-05-06 through 2026-05-11. Most pieces are in Health, World, Politics, and Business. Newest first below.

21 stories in this view · page 1 of 1

4 stories
Clinical healthcare facility interior — illustrative imagery for Newsorga's careful explainer on Russia's experimental cancer treatment EnteroMix, an oncolytic virotherapy using four live replication-competent human enteroviruses including Coxsackievirus A21, Echovirus 7, Enterovirus B75 and a Sabin-derived modified poliovirus PV-Russo, still in Phase I clinical trials and the subject of unconfirmed media reports in early May 2026 that China is preparing regulatory approval through its National Medical Products Administration.

Health

Russia's EnteroMix and China's approval rumour: what's true, what isn't

Multiple media outlets reported in early May 2026 that China is preparing to approve Russia's experimental cancer vaccine EnteroMix, but the claim sits on top of a stack of public confusion — there are three distinct Russian cancer-vaccine programmes (EnteroMix, a separate personalized mRNA vaccine being developed by the National Medical Research Radiological Center and Gamaleya Center, and the Federal Medical and Biological Agency's FMBA colorectal-cancer vaccine that head Veronika Skvortsova said on TASS in September 2025 was 'ready for clinical use'); EnteroMix specifically is an oncolytic virotherapy using four live replication-competent enteroviruses (Coxsackievirus A21, Echovirus 7, Enterovirus B75 and a Sabin-derived PV-Russo poliovirus modification) administered intravenously — not an mRNA vaccine despite widespread mislabelling — and it remains in Phase I human clinical trials that began with 48 volunteers in June 2025 and are scheduled to run until October 2026, with no peer-reviewed publications, no listing in ClinicalTrials.gov or other international registries, no public release of full viral genome sequences as required under WHO Global Polio Eradication Initiative protocols, and no official public confirmation of approval or even formal evaluation from China's National Medical Products Administration.

9 min read

Female clinician in white coat reviewing ultrasound scans on a backlit display in a hospital setting — illustrative imagery for Newsorga's analysis of rising infertility among women in India, drawing on the 2026 PMC systematic review and meta-analysis placing prevalence at 8% among women aged 15-49, the National Family Health Survey-5 figure of 18.7 per 1,000 currently-married women, the ICMR-NIRRCH December 2025 study on out-of-pocket IVF costs exceeding ₹1 lakh per cycle, and clinician observations of diminished ovarian reserve appearing in women in their late 20s rather than late 30s.

Health

India's quiet infertility surge: rising PCOS, costly IVF, no insurance cover

Female infertility is no longer a fringe concern in India: a 2026 systematic review and meta-analysis published on PMC pooled studies from 1997-2023 and placed overall infertility prevalence among Indian women aged 15-49 at 8% — with 5% primary and 2% secondary infertility — while the National Family Health Survey-5 (NFHS-5, 2019-21) reports 18.7 per 1,000 currently-married women under a stricter five-year-no-conception definition; clinicians at AIIMS Delhi, Sitaram Bhartia Institute and Sir Ganga Ram Hospital tell Times of India that diminished ovarian reserve is now appearing in women in their late 20s instead of late 30s, PCOS affects 10-17.4% of reproductive-age women, and the December 2025 ICMR-NIRRCH cost study published via The Hindu found average out-of-pocket IVF spending above ₹1 lakh per cycle in both private and public hospitals while fertility care remains outside the Pradhan Mantri Jan Arogya Yojana (PM-JAY) package and ART pricing remains unregulated under the 2021 Act.

10 min read

Commercial jet aircraft on an airport apron at dusk with ground crew vehicles nearby — illustrative imagery for Newsorga's coverage of coordinated international repatriation flights carrying MV Hondius passengers from Tenerife after the May 2026 Andes hantavirus outbreak, including newly reported positive cases among evacuees routed to France and the United States.

Health

Two more MV Hondius passengers test positive for Andes hantavirus amid global repatriation

As orchestrated waves of evacuations began from the MV Hondius after it docked at Granadilla de Abona on Tenerife on Sunday May 10, 2026, authorities reported at least two additional laboratory-linked positives among passengers already in motion toward home countries — one American evacuated with the United States charter whose PCR result United States officials classified as a mildly positive Andes-strain detection and one French woman whose symptoms escalated during her repatriation flight to Paris and who tested positive after landing at Le Bourget in care now overseen by French Health Minister Stéphanie Rist — while Spanish Health Ministry officials continued to dispute Washington's interpretation of the weak-positive United States case as inconclusive by European laboratory standards, and while the European Centre for Disease Prevention and Control's snapshot as of 14:00 Central European Time on May 10 still listed eight outbreak-associated cases — six confirmed and two probable — across the Dutch-flagged expedition vessel whose passengers and crew represented twenty-three countries.

9 min read

Health

17 Americans begin 42-day hantavirus monitoring at UNMC after MV Hondius outbreak

A US government charter flight carrying seventeen American citizens and one British national who lives in the United States — all of them previously aboard the MV Hondius expedition cruise ship caught up in the World Health Organization-coordinated Andes hantavirus outbreak that has killed three passengers since April 11 and produced six laboratory-confirmed and two probable cases — landed at Omaha's Eppley Airfield shortly before 2:30 a.m. local time on Monday May 11, 2026, with one passenger who tested 'mildly' positive for the virus transported directly to the Nebraska Biocontainment Unit and the rest moved to the only federally funded National Quarantine Unit in the United States at the University of Nebraska Medical Center for assessment and onward 42-day daily health monitoring, in a federal response that NIH director and acting CDC chief Dr. Jay Bhattacharya described as 'following the safety protocols previously used successfully during a 2018 outbreak of the same hantavirus strain' and that WHO Director-General Tedros Adhanom Ghebreyesus has framed as 'not another Covid-19.'

9 min read

9 stories

Politics

Mifepristone back at the Supreme Court: Alito's May 4 stay, Louisiana's standing theory and the May 11 cliff edge explained

Justice Samuel Alito's May 4 administrative stay temporarily restored nationwide telehealth and mail access to the abortion pill mifepristone after the 5th Circuit ordered the FDA to revert to in-person dispensing; the full Supreme Court must now decide—by May 11 at 5 p.m. EDT—whether Louisiana has standing to force that change while litigation continues.

11 min read

Health

MV Hondius anchors in Tenerife as 147 people disembark in WHO-coordinated Andes-virus evacuation to seven countries

The Dutch expedition ship MV Hondius, operated by Oceanwide Expeditions on a five-week Antarctic and South Atlantic itinerary that left Ushuaia on April 1, 2026, arrived at the Port of Granadilla in Tenerife at about 5:30 a.m. local time on Sunday May 10, 2026 with 147 people on board and three confirmed deaths in transit; Spanish health minister Monica Garcia called the disembarkation 'unprecedented' as passengers were taken by speedboat directly to evacuation flights for six European countries and Canada under World Health Organization, ECDC and CDC coordination, with the Andes hantavirus — the only hantavirus known to spread between people in close, sustained contact — confirmed by gene sequencing on May 4 and the index case linked to a four-month overland trip the 70-year-old Dutch passenger took through Chile, Uruguay and Argentina before boarding at Ushuaia.

9 min read

4 stories

4 stories

Health

Cancer ‘cures’: myths, facts, and a clear-eyed guide to what medicine can—and cannot—promise today

Cancer is not one disease. Some forms can be eliminated for good in many patients; others are driven into long remission; still others remain difficult to control once advanced. This report uses WHO and U.S. National Cancer Institute framing on prognosis, separates hype from evidence, and explains when early treatment, screening, and specialist care matter most.

20 min read